Browse by Authors and Editors

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Article
Number of items: 5.

Article

Patel, Poulam M. and Ottensmeier, Christian H. and Mulatero, Clive and Lorigan, Paul and Plummer, Ruth and Pandha, Hardev S. and Elsheikh, Somaia and Hadjimichael, Efthymios and Villasanti, Naty and Cunnell, Michelle and Metheringham, Rachael L. and Brentville, Victoria A. and Machado, Lee and Daniels, Ian and Gijon, Mohamed and Hannaman, Drew and Durrant, Lindy (2018) Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. Oncoimmunology . ISSN 2162-402X (In Press)

Cook, Katherine and Daniels, Ian and Symonds, Peter and Pitt, Tracy and Gijon, Mohamed and Xue, Wei and Metheringham, Rachael L. and Durrant, Lindy and Brentville, Victoria A. (2018) Citrullinated α-enolase is an effective target for anti-cancer immunity. Oncoimmunology, 7 (2). ISSN 2162-402X

Xue, Wei and Brentville, Victoria A. and Symonds, Peter and Cook, Katherine and Yagita, Hideo and Metheringham, Rachael L. and Durrant, Lindy (2016) SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors. Oncotarget, 7 (50). pp. 83088-83100. ISSN 1949-2553

Xue, Wei and Metheringham, Rachael L. and Brentville, Victoria A. and Gunn, Barbara and Symonds, Peter and Yagita, Hideo and Ramage, Judith M. and Durrant, Lindy (2016) SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade. Oncoimmunology, 5 (6). e1169353/1-e1169353/13. ISSN 2162-402X

Brentville, Victoria A. and Metheringham, Rachael L. and Gunn, Barbara and Symonds, Peter and Daniels, Ian and Gijon, Mohamed and Cook, Katherine and Xue, Wei and Durrant, Lindy (2016) Citrullinated vimentin presented on MHC-II in tumor cells is a target for CD4+ T-cell-mediated antitumor immunity. Cancer Research, 76 (3). pp. 548-560. ISSN 1538-7445

This list was generated on Sat Feb 27 19:58:58 2021 UTC.